Home/Filings/4/A/0001104659-25-116084
4/A//SEC Filing

Hoffman Michael B 4/A

Accession 0001104659-25-116084

CIK 0001477845other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 6:59 PM ET

Size

10.5 KB

Accession

0001104659-25-116084

Insider Transaction Report

Form 4/AAmended
Period: 2025-11-24
Transactions
  • Purchase

    Common Stock

    2025-11-24$4.13/sh+1,489$6,1502,492,028 total
  • Purchase

    Common Stock

    2025-11-24$4.15/sh+28,096$116,5982,529,739 total
  • Purchase

    Common Stock

    2025-11-24$3.85/sh+9,200$35,4202,501,228 total
  • Purchase

    Common Stock

    2025-11-24$4.14/sh+415$1,7182,501,643 total
Holdings
  • Common Stock

    (indirect: By Trust)
    223,357
Footnotes (1)
  • [F1]The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.

Issuer

Annovis Bio, Inc.

CIK 0001477845

Entity typeother

Related Parties

1
  • filerCIK 0001290208

Filing Metadata

Form type
4/A
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 6:59 PM ET
Size
10.5 KB